Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 18.0% in January
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,420,000 shares, a decline of 18.0% from the January 15th total of 2,950,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,420,000 shares, a decline of 18.0% from the January 15th total of 2,950,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average […]
